US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

248.72

-0.9300-0.37%

Post-market: 250.001.28+0.51%19:59 EDT

Volume:344.92K

Turnover:86.47M

Market Cap:565.71M

PE:- -

High:259.39

Open:256.76

Low:244.53

Close:249.65

52wk High:341.93

52wk Low:100.18

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.06

T/O Rate:15.16%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sector Update: Healthcare

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

Press Release: Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (fshd) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Oruka Therapeutics (ORKA) and Harmony Biosciences Holdings (HRMY)

aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

Analysts Offer Insights on Healthcare Companies: Royalty Pharma (RPRX), Travere Therapeutics (TVTX) and Veeva Systems (VEEV)

FDA import ban puts Sheng Nuo Biotec's US business on red alert

Health Care Roundup: Market Talk

Sonic Healthcare Issues New Performance Rights Under Employee Incentive Scheme

Sonic Healthcare Options Lapse Simplifies Capital Structure

Global Multi-Cancer Early Screening Clears FDA Expert Panel, BGI Genomics' Early Screening Business Approaches Next Product Realization Window

Kenedix Office REIT Accelerates Asset Reshuffle with Healthcare Exit and New Acquisitions

KDX Realty Investment Reshapes Portfolio with Office, Residential and Hotel Buys, Healthcare Sale

Kringle Pharma Submits IND Application for Spinal Cord Injury Drug to U.S. FDA; Shares Jump 7%

MT Newswires Live

FDA Advisory Panel Endorses Blood Test Designed to Detect Dozens of Cancer Types, Signaling a Potential New Era for AI-Powered Screening

Malaysia Healthcare Sector Likely Supported by Structural Demand

3 ETFs That Could Deliver 11%+ Returns, According to the AI Analyst

Nexsen Refines StrepSure After Interim Trial, Nudging Back U.S. FDA Timeline

Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/LABU/news?page=14"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":248.72,"timestamp":1790971200000,"preClose":249.65,"halted":0,"volume":344920,"hourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"delay":0,"changeRate":-0.003725215301422018,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Market Closed","change":-0.93,"latestTime":"10-02 16:00:00 EDT","open":256.755,"high":259.39,"low":244.53,"amount":86471147.3688,"amplitude":0.059523,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":249.65,"sharesOutstanding":3074486,"nav":248.875,"aum":566062383.8,"dividendRate":0.003633,"bidAskSpread":0.003777,"preHourTrading":{"tag":"盘前","latestPrice":256,"preClose":249.65,"latestTime":"09:27 EDT","volume":5553,"amount":1438964.4383999999,"timestamp":1790947678782,"change":6.35,"changeRate":0.025436,"amplitude":0.043381},"postHourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"volumeRatio":1.055472560797593,"impliedVol":0.9378,"impliedVolPercentile":0.5618},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.055472560797593,"shares":2274486,"dividePrice":0.9037,"high":259.39,"amplitude":0.059523,"preClose":249.65,"low":244.53,"week52Low":100.18,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":248.72,"eps":0,"divideRate":0.003633,"volume":344920,"delay":0,"ttmEps":0,"open":256.755,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":252.47,"twentyDayClose":305.86,"sixtyDayClose":324.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:14,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669493651","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2669493651","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669493651?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:02","pubTimestamp":1790254979,"startTime":"0","endTime":"0","summary":"Healthcare stocks were flat to higher pre-bell Thursday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  up 0.3%.ACADIA Pharmaceuticals  shares were down more than 4% in premarket activity after the company reported that its phase 2 RADIANT study of remlifanserin for Alzheimer's disease psychosis narrowly missed its primary endpoint.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","LU2065171311.SGD","XBI","HCSG","LABU","ACAD","LU0029874061.USD","BK4137","XLV","BK4581","BK4585","BK4139","LU2065169927.USD","BK4588","LU2065170008.USD","IBB","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669049359","title":"Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669049359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669049359?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:50","pubTimestamp":1790254216,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Aethlon Medical (AEMD) and Kyverna Therapeutics, I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aethlon-medical-aemd-and-kyverna-therapeutics-inc-kytx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aethlon-medical-aemd-and-kyverna-therapeutics-inc-kytx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0029874061.USD","XLV","BK4568","HCSG","BK4137","BK4585","BK4588","AEMD","XBI","BK4581","LABU","BK4082","BK4583","KYTX","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669934134","title":"Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2669934134","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669934134?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":"Montreal Heart Institute Joins Multinational Study Evaluating a Self-Administered 70 mg Repeat-Dose Regimen of EtripamilMONTREAL and CHARLOTTE, N.C., Sept.  24, 2026 (GLOBE NEWSWIRE) -- Milestone Phar","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368250/0/en/milestone-pharmaceuticals-enrolls-first-canadian-study-participant-in-revera-301-phase-3-pivotal-trial-evaluating-etripamil-nasal-spray-for-afib-rvr.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VR","IDNA","BK4129","MEDX","BK4585","LU1559883803.SGD","NVIB","LU0566484027.USD","GDOC","HYLG","AV","ECG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669646251","title":"Press Release: Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (fshd) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2669646251","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669646251?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:00","pubTimestamp":1790247600,"startTime":"0","endTime":"0","summary":"-- FDA clearance expands development of forazapadin into a second. degenerative muscle disease with significant unmet medical need. -- FSHD Canada Foundation to provide up to US$5 million in non-dilutive. financing toward the clinical development of forazapadin in FSHD. \"The collaboration between Satellos and the FSHD Canada Foundation provides non-dilutive capital to advance forazapadin's clinical development in FSHD. Under the agreement, the Foundation has agreed to contribute up to US$5 million in milestone payments over the next five quarters in exchange for a capped revenue-sharing interest in future FSHD-related proceeds. The funds are expected to support the IND-cleared Phase 2 randomized, double-blind, placebo-controlled proof-of-concept clinical study designed to evaluate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4139","BMED","BK4585","MSLE","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669464161","title":"Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Oruka Therapeutics (ORKA) and Harmony Biosciences Holdings (HRMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669464161?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:30","pubTimestamp":1790245831,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX), Oruka Therapeutic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-oruka-therapeutics-orka-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-oruka-therapeutics-orka-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","IE00BFTCPJ56.SGD","LABU","XLV","XBI","PRAX","ORKA","BK4137","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","HRMY","BK4585","IBRN","IE0002141913.USD","BK4139","IE00B4R5TH58.HKD","IE0009355771.USD","LU0320765992.SGD","BK4007","LU0029874061.USD","LU0889565916.HKD","IE00BJT1NW94.SGD","BK4588","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669246156","title":"aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669246156","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669246156?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:00","pubTimestamp":1790244000,"startTime":"0","endTime":"0","summary":"Global Phase 3 study will evaluate efzofitimod in patients with pulmonary sarcoidosis with restrictive lung disease utilizing FVC as primary endpoint. Company expects to initiate study-related activit","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368118/0/en/atyr-pharma-announces-alignment-with-fda-on-phase-3-study-of-efzofitimod-in-pulmonary-sarcoidosis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588","FVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669770466","title":"Analysts Offer Insights on Healthcare Companies: Royalty Pharma (RPRX), Travere Therapeutics (TVTX) and Veeva Systems (VEEV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669770466","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669770466?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:30","pubTimestamp":1790242220,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Royalty Pharma (RPRX), Travere Therapeutics (TVTX) a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-royalty-pharma-rprx-travere-therapeutics-tvtx-and-veeva-systems-veev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-royalty-pharma-rprx-travere-therapeutics-tvtx-and-veeva-systems-veev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0006306889.USD","LU1989764748.USD","BK4137","LFSC","FFTY","XLV","LU0106261372.USD","LABU","LU0128526141.USD","BK4585","BK4588","LU1989764664.SGD","BK4007","BK4581","RPRX","LU0029874061.USD","BK4167","BK4534","VEEV","BK4528","TVTX","EKG","LU0170899867.USD","XBI","BK4139","LGHT","IHE","LU0289739699.SGD","HCSG","BK4504","LU0266013472.USD","BK4613","PBE","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193027650","title":"FDA import ban puts Sheng Nuo Biotec's US business on red alert","url":"https://stock-news.laohu8.com/highlight/detail?id=1193027650","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193027650?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:40","pubTimestamp":1790239239,"startTime":"0","endTime":"0","summary":"After its subsidiary Sheng Nuo Pharmaceutical underwent an on-site FDA inspection, peptide CDMO company Chengdu Sheng Nuo Biotec Co.,Ltd. (688117) received a Form 483 observation list and was...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LABU","BK4585","688117","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669042468","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2669042468","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669042468?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:20","pubTimestamp":1790238000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0721 GMT - Hikma Pharmaceuticals' new chief financial officer is","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LABU","BK4581","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669826468","title":"Sonic Healthcare Issues New Performance Rights Under Employee Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2669826468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669826468?lang=en_us&edition=fundamental","pubTime":"2026-09-24 15:48","pubTimestamp":1790236106,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Sonic Healthcare Limited ( ($AU:SHL) ). Sonic Healthcare Limited has notified the market of the issue of 72,014...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sonic-healthcare-issues-new-performance-rights-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sonic-healthcare-issues-new-performance-rights-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","XLV","BK4588","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669468817","title":"Sonic Healthcare Options Lapse Simplifies Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669468817","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669468817?lang=en_us&edition=fundamental","pubTime":"2026-09-24 15:34","pubTimestamp":1790235274,"startTime":"0","endTime":"0","summary":"An announcement from Sonic Healthcare Limited ( ($AU:SHL) ) is now available. Sonic Healthcare Limited has notified the market of the cessation of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sonic-healthcare-options-lapse-simplifies-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sonic-healthcare-options-lapse-simplifies-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","XBI","BK4581","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155851563","title":"Global Multi-Cancer Early Screening Clears FDA Expert Panel, BGI Genomics' Early Screening Business Approaches Next Product Realization Window","url":"https://stock-news.laohu8.com/highlight/detail?id=1155851563","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155851563?lang=en_us&edition=fundamental","pubTime":"2026-09-24 15:21","pubTimestamp":1790234511,"startTime":"0","endTime":"0","summary":"On September 23, Eastern Time, the Molecular and Clinical Genetics Panel, a subdivision of the FDA's Medical Devices Advisory Committee, convened a public meeting to review GRAIL's Premarket Approval...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK0221","BK4585","300676","BK4588","LABU","BK0042","BK0046","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669034452","title":"Kenedix Office REIT Accelerates Asset Reshuffle with Healthcare Exit and New Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2669034452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669034452?lang=en_us&edition=fundamental","pubTime":"2026-09-24 14:55","pubTimestamp":1790232939,"startTime":"0","endTime":"0","summary":"Kenedix Office Investment Corporation ( ($JP:8972) ) has provided an announcement. Kenedix Office Investment Corporation announced a series of acqu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kenedix-office-reit-accelerates-asset-reshuffle-with-healthcare-exit-and-new-acquisitions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kenedix-office-reit-accelerates-asset-reshuffle-with-healthcare-exit-and-new-acquisitions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCF","DFRA","HCSG","XLV","BK4585","IVRA","BK4581","BK4588","LU0029874061.USD","XBI","BK4137","LABU","LU0128526141.USD","RJMG","YLDW","BPRE","IQRA","MDIV","RNTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669452012","title":"KDX Realty Investment Reshapes Portfolio with Office, Residential and Hotel Buys, Healthcare Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2669452012","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669452012?lang=en_us&edition=fundamental","pubTime":"2026-09-24 14:55","pubTimestamp":1790232928,"startTime":"0","endTime":"0","summary":"Kenedix Office Investment Corporation ( ($JP:8972) ) just unveiled an update. KDX Realty Investment Corporation will acquire one office building in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kdx-realty-investment-reshapes-portfolio-with-office-residential-and-hotel-buys-healthcare-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kdx-realty-investment-reshapes-portfolio-with-office-residential-and-hotel-buys-healthcare-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","BK4137","LABU","LU0128526141.USD","LU0029874061.USD","XBI","XLV","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669456062","title":"Kringle Pharma Submits IND Application for Spinal Cord Injury Drug to U.S. FDA; Shares Jump 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669456062","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669456062?lang=en_us&edition=fundamental","pubTime":"2026-09-24 12:21","pubTimestamp":1790223665,"startTime":"0","endTime":"0","summary":"Kringle Pharma  submitted an Investigational New Drug  application to the U.S. Food and Drug Administration  to initiate a phase three clinical trial in the U.S. for acute spinal cord injury drug oremepermin alfa.The proprietary recombinant human HGF therapeutic, Oremepermin alfa, completed phase one/two and phase three trials in Japan for acute spinal cord injury, the late-stage clinical biopharmaceutical company said in a Thursday filing with the Japan bourse.The company is carrying out an additional Phase 3 trial to support a future regulatory submission, while the drug has secured orphan drug designation for acute SCI in Japan, the U.S. and Europe, it said.Shares of Kringle Pharma added nearly 7% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4585","IND.AU","BK7095","BK4588","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165545226","title":"FDA Advisory Panel Endorses Blood Test Designed to Detect Dozens of Cancer Types, Signaling a Potential New Era for AI-Powered Screening","url":"https://stock-news.laohu8.com/highlight/detail?id=1165545226","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165545226?lang=en_us&edition=fundamental","pubTime":"2026-09-24 10:26","pubTimestamp":1790216790,"startTime":"0","endTime":"0","summary":"On September 23, 2026, the field of multi-cancer early detection reached a significant milestone. The U.S. FDA's Molecular and Clinical Genetics Panel reviewed GRAIL's Galleri multi-cancer early...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTOC","ARTY","AIPO","BK4588","AGIX","VTHR","BK4585","CHAT","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669453675","title":"Malaysia Healthcare Sector Likely Supported by Structural Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2669453675","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669453675?lang=en_us&edition=fundamental","pubTime":"2026-09-24 10:20","pubTimestamp":1790216400,"startTime":"0","endTime":"0","summary":"0220 GMT - Malaysian healthcare sector could remain supported by the rising prevalence of non-communicable diseases, an ageing population, and increasing health awareness, CIMB Securities analyst Chun Sung Oong says in a note. He pegs IHH Healthcare as his new top pick, citing its stronger earnings visibility. IHH's business is expected to benefit from patients shifting to private hospitals amid high occupancy at public hospitals. In India, Gleneagles India's profitability is expected to improve as it works more closely with Fortis Healthcare. The potential IPO of AsiaOne Healthcare could renew investor interest in Malaysia's healthcare sector, as the listing could support higher valuations, he adds. CIMB maintains an overweight rating on the Malaysian healthcare sector.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4581","HCSG","XLV","LU0128526141.USD","LU0029874061.USD","LABU","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430290","title":"3 ETFs That Could Deliver 11%+ Returns, According to the AI Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430290","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669430290?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:13","pubTimestamp":1790212391,"startTime":"0","endTime":"0","summary":"TipRanks’ ETF AI Analyst has an Outperform rating on the Schwab U.S. Dividend Equity ETF ($SCHD), Health Care Select Sector SPDR Fund ($XLV), and V...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-etfs-that-could-deliver-11-returns-according-to-the-ai-analyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-etfs-that-could-deliver-11-returns-according-to-the-ai-analyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","QTOC","BK4588","AGIX","CHAT","FDN","XLV","LABU","VTHR","SCHD","BK4581","AIPO","ARTY","BK4550","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669374874","title":"Nexsen Refines StrepSure After Interim Trial, Nudging Back U.S. FDA Timeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2669374874","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669374874?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:37","pubTimestamp":1790210252,"startTime":"0","endTime":"0","summary":"Nexsen Limited ( ($AU:NXN) ) has issued an update. Nexsen Limited has halted enrollment in its Melbourne clinical study of StrepSure after a planne...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexsen-refines-strepsure-after-interim-trial-nudging-back-u-s-fda-timeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexsen-refines-strepsure-after-interim-trial-nudging-back-u-s-fda-timeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669437128","title":"Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches","url":"https://stock-news.laohu8.com/highlight/detail?id=2669437128","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669437128?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:30","pubTimestamp":1790209807,"startTime":"0","endTime":"0","summary":"An announcement from Mesoblast Limited ( ($AU:MSB) ) is now available. Mesoblast has secured U.S. FDA approval for a new T-cell Proliferation Inhib...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4585","PINK","NVIB","PSCH","TBXU","BK4588","IBB","MRNY","SYNB","GDOC","GNMX","BMED","XLVX","LFSC","MESO","LABU","IYH","FRTY","MEDI","TECB","RSPH","BK4139","BBP","IEIH","MRNX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":14,"totalSize":396,"code":"91000000","status":"200"}]}}